Cocrystal Pharma, Inc. (COCP) vs Lipocine Inc. (LPCN)

A side-by-side comparison of Cocrystal Pharma, Inc. and Lipocine Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COCP vs LPCN

growth of $100 · dividends reinvested · last 10y
COCP -99.4% (-39.8%/yr)LPCN -97.2% (-30.0%/yr)LPCN compounded faster over this window
050100Start $10020182020202220242026$1$3
COCP LPCN

COCP vs LPCN: by the numbers

  • •LPCN is the larger company ($17M vs $15M market cap).
  • •Both run net losses; LPCN's is the smaller (-755.13% vs -3011.52% net margin).

Metrics side by side

Valuation

MetricCOCPLPCN
P/S ratio46.7910.93
P/B ratio14.790.79

Profitability

MetricCOCPLPCN
Gross margin0.00%-334.26%
Operating margin0.00%-524.69%
Net margin-3011.52%-755.13%
ROE-951.92%-54.45%
ROIC-497.29%-57.74%

Growth (annualized)

MetricCOCPLPCN
Revenue CAGR (5Y)91.55%N/A
Total return CAGR (5Y)-37.50%-34.76%

Frequently asked

How have COCP and LPCN total returns compared?
Over the past 10 years, COCP delivered -39.76% and LPCN delivered -29.99% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.